Compare Twist Bioscience Corp (TWST) vs Wells Fargo & Co (WFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Twist Bioscience Corp vs Wells Fargo & Co — how do they compare? Twist Bioscience Corp trades at $124 (market cap $7.72B), while Wells Fargo & Co trades at $87.48 (market cap $264.66B). The key difference: Wells Fargo & Co is far larger — about 34.3× Twist Bioscience Corp's market cap, and Wells Fargo & Co pays a 2.29% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| TWST | WFC | |
|---|---|---|
Market Cap | $7.72B | $264.66B |
Sector | Health | Financials |
52-Week High | $124.88 | $96.40 |
52-Week Low | $24.16 | $73.42 |
Enterprise Value | $7.65B | — |
Dividend Yield | — | 2.29% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →
